Cargando…

Effects of aliskiren- and ramipril-based treatment on central aortic blood pressure in elderly with systolic hypertension: a substudy of AGELESS

BACKGROUND: Systolic hypertension is the most common form of hypertension in elderly patients. There is increasing evidence that measurement of central aortic pressure (CAP) better accounts for cardiovascular risk than brachial blood pressure (BP). The Aliskiren for GEriatric LowEring of SyStolic hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baschiera, Fabio, Chang, William, Brunel, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079630/ https://www.ncbi.nlm.nih.gov/pubmed/25061313 http://dx.doi.org/10.2147/VHRM.S63725

Ejemplares similares

Elderly or ageless? Physical Activity in the Aged Orthopaedic Patient
por: Pigozzi, Fabio, et al.
Publicado: (2020)

Comparative evaluation of aliskiren, ramipril, and losartan on psychomotor performance in healthy volunteers: A preliminary report
por: Arora, Ekta, et al.
Publicado: (2014)

Nanosilver: new ageless and versatile biomedical therapeutic scaffold
por: Ullah Khan, Shahid, et al.
Publicado: (2018)

Renin inhibition with aliskiren in hypertension: focus on aliskiren/hydrochlorothiazide combination therapy
por: Sureshkumar, Kalathil K
Publicado: (2008)

Entrepreneurial edge: everyday entrepreneur family entrepreneur ageless entrepreneur
por: Dawkins, Fred
Publicado: (2015)

Role of aliskiren in blood pressure control and renoprotection
por: Trimarchi, Hernán
Publicado: (2011)

Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Renin-angiotensin-aldosterone system in the elderly: rational use of aliskiren in managing hypertension
por: Andersen, Karl
Publicado: (2009)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

Predictors of high central blood pressure in young with isolated systolic hypertension
por: Radchenko, GD, et al.
Publicado: (2016)

Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Central systolic blood pressure and central pulse pressure predict left ventricular hypertrophy in hypertensive children
por: Litwin, Mieczysław, et al.
Publicado: (2018)

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants
por: Supiano, Mark A., et al.
Publicado: (2018)

Systolic Blood Pressure and Effects of Screening for Atrial Fibrillation With Long-Term Continuous Monitoring (a LOOP Substudy)
por: Xing, Lucas Yixi, et al.
Publicado: (2022)

Aliskiren in hypertension: evidence for its potential therapeutic value
por: Peter, Doris
Publicado: (2005)

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
por: Rashid, Haroon-Ur
Publicado: (2010)

Joint Effect of Non-invasive Central Systolic Blood Pressure and Peripheral Systolic Blood Pressure on Incident Hypertension in a Chinese Community-based Population
por: Wang, Shixuan, et al.
Publicado: (2018)

Evolution of isolated systolic hypertension with normal central blood pressure in adolescents—prospective study
por: Obrycki, Łukasz, et al.
Publicado: (2020)

Zofenopril versus ramipril in the early phase of acute myocardial infarction with systolic dysfunction: A retrospective study
por: Liu, Xiaoyang, et al.
Publicado: (2020)

Can Aliskiren be Considered as a New Novel Drug for Hypertension?
por: Bhatti, Adnan Bashir, et al.
Publicado: (2015)

Central integration and neural control of blood pressure during the cold pressor test: a comparison between hydrochlorothiazide and aliskiren
por: Jarvis, Sara S, et al.
Publicado: (2015)

Effect of bisoprolol on central aortic systolic pressure in Chinese hypertensive patients after the initial dose and long-term treatment
por: Zeng, Weiwei, et al.
Publicado: (2022)

The effects of sacubitril/valsartan and ramipril on the male fertility in hypertensive rats
por: Aykan, Duygun Altintas, et al.
Publicado: (2020)

Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design
por: Ponvel, Pavapriya, et al.
Publicado: (2021)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients
por: Fernandes, Leticia Aparecida Barufi, et al.
Publicado: (2016)

Serum Sclerostin Is Associated with Peripheral and Central Systolic Blood Pressure in Pediatric Patients with Primary Hypertension
por: Skrzypczyk, Piotr, et al.
Publicado: (2021)

Dairy consumption, systolic blood pressure, and risk of hypertension
Publicado: (2017)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
por: Bosone, Daniele, et al.
Publicado: (2016)

Aliskiren, ALTITUDE, and the implications for ATMOSPHERE
por: McMurray, John J.V., et al.
Publicado: (2012)

High prevalence of masked uncontrolled morning hypertension in elderly non‐valvular atrial fibrillation patients: Home blood pressure substudy of the ANAFIE Registry
por: Kario, Kazuomi, et al.
Publicado: (2020)

Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect
por: Panahpour, Hamdollah, et al.
Publicado: (2019)

Central Systolic Hypertension in Patients with Well-Controlled Hypertension
por: Bulas, Jozef, et al.
Publicado: (2017)

Ramipril: Angioedema: case report
Publicado: (2021)

Isolated systolic hypertension and central blood pressure: Implications from the national nutrition and health survey in Taiwan
por: Chuang, Shao‐Yuan, et al.
Publicado: (2020)

Twenty-Four–Hour Central (Aortic) Systolic Blood Pressure: Reference Values and Dipping Patterns in Untreated Individuals
por: Weber, Thomas, et al.
Publicado: (2021)

Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach
por: Morgado, Manuel P, et al.
Publicado: (2011)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)

Aliskiren and Amlodipine in the Management of Essential Hypertension: Meta-Analysis of Randomized Controlled Trials
por: Liu, Yukai, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_l11m6q895mqid6t0ql87domn4u